{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:24:25Z","timestamp":1783607065530,"version":"3.55.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research and Innovation Services fund and Development of Impactful Research fund at Cardiff Metropolitan University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine the phenotypic and genotypic antibiotic susceptibility of Mycoplasma amphoriforme isolates recovered from patients in the UK and Denmark.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seven isolates of M. amphoriforme were examined for antimicrobial susceptibility to seven antibiotics using the microbroth dilution assay in line with the CLSI guidelines for mycoplasmas. Each isolate was additionally subjected to WGS to identify resistance-associated mutations. Based on the consensus sequences from the genomic data, PCR primers were designed, and tested, for the amplification of the QRDR within the parC gene.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the seven isolates investigated, four (57%) were resistant to moxifloxacin (0.5\u20131\u2005mg\/L) and levofloxacin (1\u20132\u2005mg\/L), compared with those that were susceptible (0.03\u20130.06 and 0.006\u2005mg\/L, respectively). Isolate H29 was resistant to five of the seven antibiotics tested: moxifloxacin, 0.5\u2005mg\/L; levofloxacin, 2\u2005mg\/L; azithromycin, 64\u2005mg\/L; erythromycin, 128\u2005mg\/L; and clindamycin, 64\u2005mg\/L. All isolates were susceptible to tetracycline (0.06\u2005mg\/L) and lefamulin (0.001\u20130.004\u2005mg\/L). Mutations from genomic data confirmed the presence of an S89F mutation within the ParC protein among all fluoroquinolone-resistant isolates and an A2059G mutation in the 23S rRNA gene in the macrolide- and lincosamide-resistant isolate H29.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>To the best of our knowledge, this is the first time where phenotypic and genotypic resistance data have been paired for M. amphoriforme confirming a correlation between the two. These data suggest the need for focused testing and resistance determination of isolates from high-risk patients given the backdrop of a high prevalence of antimicrobial resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac293","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T16:29:49Z","timestamp":1662049789000},"page":"3126-3129","source":"Crossref","is-referenced-by-count":8,"title":["Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen <i>Mycoplasma amphoriforme<\/i> isolated from the UK and Denmark"],"prefix":"10.1093","volume":"77","author":[{"given":"Jessica","family":"Day","sequence":"first","affiliation":[{"name":"United Kingdom Health Security Agency, Colindale , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baharak","family":"Afshar","sequence":"additional","affiliation":[{"name":"United Kingdom Health Security Agency, Colindale , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Rowlands","sequence":"additional","affiliation":[{"name":"Microbiology and Infection Research Group, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiba S","family":"Umer","sequence":"additional","affiliation":[{"name":"Microbiology and Infection Research Group, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Windsor","sequence":"additional","affiliation":[{"name":"Mycoplasma Experience, Brewer Street Dairy Business Park , Bletchingley, Surrey , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Paukner","sequence":"additional","affiliation":[{"name":"Nabriva Therapeutics GmbH , 1110 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7435","authenticated-orcid":false,"given":"Jorgen S","family":"Jensen","sequence":"additional","affiliation":[{"name":"Research Unit for Reproductive Microbiology, Statens Serum Institut , Copenhagen, DK-2300 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen B","family":"Spiller","sequence":"additional","affiliation":[{"name":"United Kingdom Health Security Agency, Colindale , London , UK"},{"name":"Cardiff University, Division of Infection and Immunity, Department of Medical Microbiology, University Hospital of Wales , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J","family":"Chalker","sequence":"additional","affiliation":[{"name":"United Kingdom Health Security Agency, Colindale , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-0772","authenticated-orcid":false,"given":"Michael L","family":"Beeton","sequence":"additional","affiliation":[{"name":"United Kingdom Health Security Agency, Colindale , London , UK"},{"name":"Microbiology and Infection Research Group, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University , Cardiff , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Mestrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pereyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Van Der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2022102819182081100_dkac293-B1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10096-003-0980-9","article-title":"Chronic bronchitis in immunocompromised patients: association with a novel Mycoplasma species","volume":"22","author":"Webster","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022102819182081100_dkac293-B2","doi-asserted-by":"crossref","first-page":"1697.e1","DOI":"10.1016\/j.cmi.2021.06.021","article-title":"Molecular exploration for Mycoplasma amphoriforme, Mycoplasma fermentans and Ureaplasma spp. in patient samples previously investigated for Mycoplasma pneumoniae infection","volume":"27","author":"Rehman","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022102819182081100_dkac293-B3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1099\/jmm.0.000809","article-title":"Mycoplasma amphoriforme vs M. pneumoniae: similarities and differences between patient characteristics in a regional hospital in the Netherlands","volume":"67","author":"van Schaik","year":"2018","journal-title":"J Med Microbiol"},{"key":"2022102819182081100_dkac293-B4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7883\/yoken.JJID.2016.128","article-title":"Novel isolation of Mycoplasma amphoriforme from a pediatric patient with protracted bronchitis in Japan","volume":"69","author":"Katsukawa","year":"2016","journal-title":"Jpn J Infect Dis"},{"key":"2022102819182081100_dkac293-B5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/JCM.03049-13","article-title":"Tools for detection of Mycoplasma amphoriforme: a primary respiratory pathogen?","volume":"52","author":"Ling","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2022102819182081100_dkac293-B6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1469-0691.2009.02993.x","article-title":"Detection and susceptibility testing of Mycoplasma amphoriforme isolates from patients with respiratory tract infections","volume":"16","author":"Pereyre","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2022102819182081100_dkac293-B7","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1099\/ijs.0.63269-0","article-title":"Mycoplasma amphoriforme sp. nov., isolated from a patient with chronic bronchopneumonia","volume":"55","author":"Pitcher","year":"2005","journal-title":"Int J Syst Evol Microbiol"},{"key":"2022102819182081100_dkac293-B8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciu820","article-title":"Genomic investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen","volume":"60","author":"Gillespie","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022102819182081100_dkac293-B9","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02432-21","article-title":"Macrolide resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021","volume":"66","author":"Rothstein","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2022102819182081100_dkac293-B10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2022102819182081100_dkac293-B11","volume-title":"Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas: M43-A","author":"CLSI","year":"2011"},{"key":"2022102819182081100_dkac293-B12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1128\/AAC.02008-16","article-title":"In vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022102819182081100_dkac293-B13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/antibiotics10121489","article-title":"Lefamulin in patients with community-acquired bacterial pneumonia caused by atypical respiratory pathogens: pooled results from two phase 3 trials","volume":"10","author":"Paukner","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2022102819182081100_dkac293-B14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"2022102819182081100_dkac293-B15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.00889-15","article-title":"Antibiotic resistance among clinical Ureaplasma isolates recovered from neonates in England and Wales between 2007 and 2013","volume":"60","author":"Beeton","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2022102819182081100_dkac293-B16","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/antibiotics10101216","article-title":"Integrating the human and animal sides of mycoplasmas resistance to antimicrobials","volume":"10","author":"Pereyre","year":"2021","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/11\/3126\/46680420\/dkac293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/11\/3126\/46680420\/dkac293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T19:21:50Z","timestamp":1666984910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/11\/3126\/6681125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2022,10,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac293","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,2]]},"published":{"date-parts":[[2022,9,1]]}}}